CSG452

DRUG3 trials

Sponsors

Kowa Research Institute, Inc.

Conditions

HealthyNASH

Phase 1

Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers

CompletedNCT04237597

Kowa Research Institute, Inc.Healthy

Start: 2019-12-17End: 2020-03-04Updated: 2020-09-22

Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452

CompletedNCT05722262

Kowa Research Institute, Inc.Healthy

Start: 2023-02-24End: 2023-04-05Updated: 2023-06-02

Phase 2

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

CompletedNCT05327127

Kowa Research Institute, Inc.NASH

Start: 2022-11-14End: 2026-06-03Updated: 2026-06-26